Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Review the latest news and information on the Coronavirus Pandemic.
read more
Clinigen has signed an exclusive agreement with Xeris to manage the supply and distribution of Gvoke injection, a treatment for diabetes, outside the US.
read more
Hetero has entered into a licensing agreement with Gilead Sciences for the manufacturing and distribution of Remdesivir for the treatment of Covid-19.
read more
SubjectWell has developed a growing patient registry of individuals in the US interested in participating in clinical trials for a COVID-19 vaccine as these trials become more widely available.
read more
Relief and NeuroRx announced NeuroRx has completed final manufacturing of intravenous RLF-100 as a potential treatment for COVID-19 ventilated patients with ARDS.
read more
Sabin announced BARDA has exercised the first two options, valued at $20 million advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.
read more
Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19.
read more
Vibalogics will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by the Janssen Pharmaceutical Companies of Johnson & Johnson.
read more
ApiJect Systems America has been awarded an HHS-DOD Title 3, DPA contract to accelerate the building of a new U.S.-based, high-speed, population-scale emergency drug injection capability with prefilled syringes from its subsidiary RAPID USA Inc.
read more
MasterPharm is voluntarily recalling 1 lot of Finasteride Plus 1.25mg, capsules to the consumer level.
read more
Fluxergy is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer diagnostic testing system in response to the COVID-19 pandemic.
read more
Parexel has unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks.
read more
QPS has announced a newly developed capability to conduct COVID-19 testing, available as of May 11, 2020.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
read more